How Big Pharma Is Turning Industrial Heat Into A Strategic Asset
Big Pharma companies like AstraZeneca are increasingly focusing on decarbonizing industrial heat, a significant source of emissions within their supply chains. Geopolitical events and resulting energy price volatility have created a strong business case for reducing reliance on natural gas for heat generation. AstraZeneca's Clean Heat Program, developed with Secaro and ERM, aims to systematically reduce these emissions across its supplier network, prioritizing cost reduction and business resilience alongside sustainability. AI
IMPACT N/A